Vogt Florian, Van den Bergh Rafael, Bernasconi Andrea, Moyo Buhlebenkosi, Havazvidi Liberty, Bastard Mathieu, Flevaud Laurence, Taziwa Fabian, Makondo Eliphas, Mtapuri-Zinyowera Sekesai
Operational Centre Barcelona, Médecins Sans Frontières / Doctors Without Borders, Barcelona, Spain.
Operational Research Unit Luxembourg, Médecins Sans Frontières / Doctors Without Borders, Luxembourg, Luxembourg.
PLoS One. 2015 Aug 21;10(8):e0136537. doi: 10.1371/journal.pone.0136537. eCollection 2015.
Blood collected in conventional EDTA tubes requires laboratory analysis within 48 hours to provide valid CD4 cell count results. This restricts access to HIV care for patients from rural areas in resource-constraint settings due to sample transportation problems. Stabilization Tubes with extended storage duration have been developed but not yet evaluated comprehensively.
To investigate stability of absolute CD4 cell count measurement of samples in BD Vacutainer CD4 Stabilization Tubes over the course of 30 days.
This was a laboratory-based method comparison study conducted at a rural district hospital in Beitbridge, Zimbabwe. Whole peripheral blood from 88 HIV positive adults was drawn into BD Vacutainer CD4 Stabilization Tubes and re-tested 1, 2, 3, 5, 7, 14 and 30 days after collection on BD FacsCount and Partec Cyflow cytometers in parallel. Absolute CD4 cell levels were compared to results from paired samples in EDTA tubes analysed on BD FacsCount at the day of sample collection (references methodology). Bland-Altman analysis based on ratios of the median CD4 counts was used, with acceptable variation ranges for Limits of Agreements of +/-20%.
Differences in ratios of the medians remained below 10% until day 21 on BD FacsCount and until day 5 on Partec Cyflow. Variations of Limits of Agreement were beyond 20% after day 1 on both cytometers. Specimen quality decreased steadily after day 5, with only 68% and 40% of samples yielding results on BD FacsCount and Partec Cyflow at day 21, respectively.
We do not recommend the use of BD Vacutainer CD4 Stabilization Tubes for absolute CD4 cell count measurement on BD FacsCount or Partec Cyflow due to large variation of results and decay of specimen quality. Alternative technologies for enhanced CD4 testing in settings with limited laboratory and sample transportation capacity still need to be developed.
采集于传统乙二胺四乙酸(EDTA)管中的血液需要在48小时内进行实验室分析,以提供有效的CD4细胞计数结果。由于样本运输问题,这限制了资源有限环境下农村地区患者获得艾滋病护理的机会。已开发出具有延长储存期限的稳定化管,但尚未进行全面评估。
研究样本在BD Vacutainer CD4稳定化管中30天内绝对CD4细胞计数测量的稳定性。
这是一项在津巴布韦贝特桥的一家农村地区医院进行的基于实验室的方法比较研究。将88名HIV阳性成年人的全外周血采集到BD Vacutainer CD4稳定化管中,并在采集后1、2、3、5、7、14和30天分别在BD FacsCount和Partec Cyflow流式细胞仪上进行重新检测。将绝对CD4细胞水平与样本采集当天在BD FacsCount上分析的EDTA管中配对样本的结果进行比较(参考方法)。采用基于CD4计数中位数比值的布兰德-奥特曼分析,一致性界限的可接受变异范围为±20%。
在BD FacsCount上,中位数比值差异在第21天之前一直低于10%,在Partec Cyflow上直到第5天一直低于10%。两台流式细胞仪在第1天之后一致性界限的变异均超过20%。第5天之后样本质量稳步下降,在第21天,分别只有68%和40%的样本在BD FacsCount和Partec Cyflow上得出结果。
由于结果差异大且样本质量下降,我们不建议在BD FacsCount或Partec Cyflow上使用BD Vacutainer CD4稳定化管进行绝对CD4细胞计数测量。在实验室和样本运输能力有限的环境中,仍需开发用于增强CD4检测的替代技术。